プレスリリース

Fiducia 株式会社は、この度、会社にとって初めてとなる 1 号ファンド（Fiducia GrowthTech 有限責任投資事業組合）を３２.６億円でファースト・クローズしたことをお知らせいたします。今後は、投資活動を開始しつつ、１年程度の期間を目途に、ファンドの規模を拡大するための資金調達活動を行います。

ファースト・クローズでは、東京理科大学インベストメント・マネジメント株式会社、株式会社南都銀行、シンガポールのパビリオン・キャピタルなどの有力な機関投資家を中心にご参加頂きました。大学のベンチャー支援を担う事業会社、地方銀行という日本の有力機関投資家に加えて、海外のプライベート・エクィティ・ファンドによる厳正な審査とご支援を受けての出発となります。
世界はすでにサイバーとリアルの一体化が進む段階に入っており、このサイバーフィジカルに向けて、半導体や通信関連の最先端技術や脱炭素の潮流の中でのEV関連技術、細胞治療を始めとする先端医療など、日本が培ってきたリアル・テクノロジーの重要性が国際的に増していくと思われます。

私たちは、Fiduciaという社名の由来である「受託者責任と社会への責任」という理念を胸に日本のリアル・テクノロジー(リアル・テック)およびヘルスケアの分野での革新的な技術やビジネスを発掘し、私どものファイナンスと投資での豊富な知見と幅広い国際的なネットワークを活用することで、投資先企業のグローバルな成長に寄与していきたいと考えています。

グローバルなマーケットでは、スタート・アップと株式公開市場の橋渡しをするグロース・キャピタルの重要性が増していますが、日本ではこの領域は未発達でありブルーオーシャンとなっています。Fiduciaは、先端のテクノロジーを有するグロース・ステージの企業に対する投資に集中することで、投資先企業の価値の増大と投資家のリターンの極大化を目指します。

共同創業者の柴田拓美のコメント

「日本経済の再活性化の鍵であるリアル・テクノロジーは、大都市圏だけでなく地方にも存在しています。地に足の着いた私たちの投資活動が、ささやかながらも日本の産業構造転換と地方創生に貢献できればこの上ない喜びです。」

共同創業者の清水時彦のコメント

「我々がフォーカスしているテクノロジー領域の特にグロース・ステージでの投資は、ホワイトスペースであり、今後の日本経済にとっても極めて重要な役割を担うでしょう。これまでの年金の運用、プライベートエクイティやベンチャー領域での幅広い投資経験を活かして、投資家の期待に応えていきたいと思います。」

Fiducia株式会社（東京都中央区日本橋兜町8-1）
http://www.fiducia.co.jp
問合せ：03-5962-3811
info@fiducia.co.jp　担当：土屋


Press Release
Fiducia Inc.
2022.2.16

Fiducia’s Inaugural Fund Launched With Initial Size of 3.3 Billion Yen; Fundraising to Continue

Fiducia Inc. announced that it has executed the first closing of its inaugural fund (Fiducia Growth Tech Limited Liability Investment Limited Partnership), with an initial size of 3.26 billion yen. The fund, which has started investments, will continue its fund-raising activity to grow in scale over the period of about one year.

The participating institutional investors of the fund include AI Capital Co., Ltd., Tokyo University of Science Investment Management Co., Ltd., Nanto Bank Co., Ltd., and Pavilion Capital. The investors range from a renowned gatekeeper and a venture capitalist to a large regional bank and a reputable Singapore-based private equity fund.

The Latin word "Fiducia" was chosen as the corporate name with the intent of executing fiduciary duties and social responsibilities. Fiducia intends to cultivate and invest in innovative companies in real technology (Real/Deep Tech) and health care innovations. Fiducia will invest in these companies and help them with expertise in finance and investments. Fiducia will help them build better business networks and, most importantly, help them to grow.
The management and employees of Fiducia will aspire to contribute to the globalization of the companies in its investment portfolio.

The integration of the virtual and the real worlds is rapidly progressing, which presents great business opportunities for Real/Deep Tech companies, including ones from Japan. Healthcare innovation from Japan's academia is advancing, but it is yet to be discovered by international investors. Fiducia focuses on investments in these two promising areas, and helps them grow to maximize investor returns.

The growth capital business bridging the gap between startups and public equity markets is now an important arena for private investments worldwide. However, this segment is underdeveloped in Japan. Fiducia aspires to help develop growth capital investments on Japanese soil to invest in and to help develop Real/Deep Tech and Health care Innovation companies.

Many large companies in Japan are rebalancing their business portfolios by spinning off non-core technologies. While some of these technologies will become more attractive if they were managed independently, they still struggle to attract financing from local venture capitalists because these companies are busy focusing on developing local IT platforms and subscription businesses. This is a perfect opportunity for Fiducia. The asset management company intends to act proactively and also work together with other counterparties to fulfill its goals.

Fiducia aims to build a balanced portfolio - not with a scattered shotgun approach but with an intentional bias toward concentration, allowing us to focus on growth investments in the Real/Deep Tech and Healthcare Innovations. This approach allows Fiducia to spend more time with the companies in which it invests, to give their management business and financial advice and to help them build business networks locally and globally.

Domestic Real/Deep Tech companies and Healthcare innovators are not limited to the Tokyo metropolitan region; they also exist in the rural regions. Fiducia hopes that its investment activities could contribute to the transformation of the industrial structure and the revitalization of rural areas.

Comments from Founders:

Takumi Shibata, Fiducia’s Co-Founder, said: "Re-energizing Japanese businesses and revitalizing regional communities will call for urgent solutions. Our focused investments in Real/Deep Tech area and in Healthcare innovations will help to solve these issues, with attractive returns to investors. Fiducia will be excited if its focused profit-seeking investment approach and returns can contribute to solving these national challenges on any scale possible.”

Tokihiko Shimizu, Fiducia’s Co-Founder, said: “Fiducia is convinced that focused investments in Real/Deep Tech and in Healthcare Innovations offer promising investment opportunities that deliver attractive returns. Growth stage investors like us are operating in a less crowded space in Japan and enjoy blue ocean-type access to investment opportunities. This is one more reason why Japan needs this growth-stage investment segment to grow. I will endeavor to contribute to building a strong, disciplined and focused investment business in order to cater to our investors’ need for returns, based on my past business experience in national pension management, private equity and venture capital investments.”

Fiducia Inc. (8-1 Nihombashi Kabutocho, Chuo-ku Tokyo) http://www.fiducia.co.jp
Contact: +81-3-5962-3811 info@fiducia.co.jp Masa Tsuchiya

プレスリリース提供：PR TIMES